Hannah Gibson, Head of Global Partners, Visiba
Hannah Gibson is Director of UK & Global Partners at Visiba, a prominent Swedish health tech/AI company. In this capacity, she has led Visiba as the technology partner of NHS England in a ground-breaking project that introduced AI into the front door of NHS urgent care. Hannah also serves as Director of the Digital Health and Care Alliance, a group established by the UK Government to aid health technology adoption.

Johnny McNamara, Invest-ability Investment Readiness Specialist, Newable
With over 20 years of experience Johnny is an expert in supporting early-stage technology companies to access the capital to grow and scale. His core strength lies in strategic capital raising advice, a critical skillset for navigating the complexities of securing investment. Currently, Johnny is part of the national operational team leading Innovate UK’s flagship investment readiness programme equipping early-stage founders across the UK with the tools, strategies, and guidance to secure investment.

Dr Neil Ebenezer, Medical Technologist and Genomics Specialist, Department for Business and Trade
Dr Neil Ebenezer has developed a portfolio career. His role at the Department for Business and Trade includes developing and implementing the global strategy for medical technologies and genomics across inward investment and exports. Neil held various posts within the civil service, including; the Department of Health where he contributed to Blood Safety and Genetics policy; was the Head of New and Emerging Technologies at the Medicines & Healthcare Products Regulatory Agency (MHRA).

Claus Andersen, Partner, Freeths
Claus is a partner in Freeths’ corporate group, specialised in assisting European & International businesses with the setting up of their UK operations. Claus’ advice support covers all aspects of corporate and commercial work with a particular focus on mergers and acquisitions, shareholder agreements, joint ventures, licencing agreements and regulatory advice to companies and businesses in the Life Sciences and technology sector.

Ivana Poparic, Head of Life Sciences Cluster Development, MedCity
Ivana is leading MedCity’s cluster development team with focus on life sciences infrastructure and real estate development as well as international relationships to attract more inward investment and research collaborations to London and beyond. Ivana has extensive scientific and commercial expertise and leadership across the innovation pathway for drugs, devices and digital technologies. Her experience includes technology transfer, clinical research, investment, and business development. 

Ilias Zapantis, Director of Discovery, UCLPartners
With over 10 years of experience Ilias is responsible for supporting the translation, adoption and spread of early innovation into the health & care system. He works with clinical partners, academic researchers & industry to co-create statements to address the needs of local population. His current portfolio of work includes early cancer detection, dementia, cardiovascular health and NHS net zero. He has led on national collaborations between industry, academia & the third sector.

Johan Aurén, Founder & Managing Director, Accountum
Based in London since 1998, Johan gained his qualification as a Chartered Accountant (ICAEW) & Chartered Tax Adviser (CIOT). He founded Accountum Limited in 2009. Johan is a Liveryman and member of the Worshipful Company of Chartered Accountants in England & Wales, a member of the London Chartered Accountants business panel at the Bank of England and the London Chartered Accountants Taxation Committee. He is a Council member of the Anglo Swedish Society and a Trustee of the Swedish Church in London.

Melina Jacovou, CEO & Founder, Propel
Melina is a driven entrepreneur that has helped many tech companies scale both in the UK and Europe. She is a a huge advocate of London and the UK, advising Tech companies on the best approach when expanding, and you may see herspeaking at events talking all things talent, growth and expansion. She works very closely with government bodies to promote the UK as a destination. She is also highly involved in promoting inclusivity.

Elisabeth Parker, Senior Investment Advisor Healthcare and Life Sciences, Business Sweden
DrParker has 25 years experience of R&D, partnership building and commercialisation of translational research through licensing and managing spin-out processes. Previously she held business development roles at Macrophage pharma and Cancer Research UK´s development and commercialisation arm and was also the Head of Research at UK quoted KS Biomedix. She currently serves as Non-Executive Director of Hamlet BioPharma and has also served as a Non-Executive Director of Arquer Diagnostics and Azeria Therapeutics

Fredrik Warneryd, Chief Executive, Swedish Chamber of Commerce for the UK
Fredrik Warneryd is the Chief Executive for the Swedish Chamber of Commerce for the UK, one of the largest and most active foreign chambers in the UK. Prior to joining the Chamber, Fredrik held many leading positions in the City of London. With more than 25 years of experience within the Nordic teams of French Banque Paribas, Dresdner Kleinwort Benson, UBS and Credit Suisse, he has earned extensive knowledge and expertise in both the UK and Nordic markets.

Anna Crona, Head of Business Development Services, Swedish Chamber of Commerce for the UK
Anna has previously had a successful corporate career at IKEA, building one of the world’s most recognised and admired brands. With an in-depth knowledge of the UK, Anna now works with the establishment and growth of Swedish companies in the UK in her role as Head of the SCC’s Business Development Services Department. Anna is on the board of directors for Pen Store AB.